| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |